Vimarsana
Biggest News Aggregation in the World

Page 2 - Care Margin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Care Margin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Care Margin Today - Breaking & Trending Today

Chronic Disease Increasing Need for Specialty Pharmacy Services - Vimarsana News

Chronic Disease Increasing Need for Specialty Pharmacy Services

/PRNewswire/ -- The average American's lifespan may have increased to 78 years old, but chronic diseases are are still prevalent. According to the CDC, six in...

Microsmallcap.com: Chronic Disease Increasing Need for Specialty Pharmacy Services - Vimarsana News

Microsmallcap.com: Chronic Disease Increasing Need for Specialty Pharmacy Services

FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Feb. 24, 2022 /PRNewswire/ -- The average American's lifespan may have increased to 78 years old, but chronic diseases

Chronic Disease Increasing Need for Specialty Pharmacy Services - Vimarsana News

Chronic Disease Increasing Need for Specialty Pharmacy Services

/PRNewswire/ -- The average American's lifespan may have increased to 78 years old, but chronic diseases are are still prevalent. According to the CDC, six in...

Financial News Media | Clinic and Telemedicine Mergers & Acquisitions Proving to be Lucrative Opportunities Heading into 2021 - Vimarsana News

Financial News Media | Clinic and Telemedicine Mergers & Acquisitions Proving to be Lucrative Opportunities Heading into 2021

Palm Beach, FL – December 10, 2020 – An overview of recent reports and articles shows that the telemedicine market is rapidly growing in all ways… there are more patients, practitioners, revenues and M&As, such as the blockbuster deal where Teladoc Health (NYSE: TDOC) is absorbing chronic care company, Livongo, in what was the biggest digital health M&A deal in 2020. In August, digital health titans Teladoc Health and Livongo announced plans to merge under the Teladoc name. The deal valued Livongo at about $18.5 billion, with Teladoc primarily purchasing the chronic care company with ...